Evidence map›Paper›PMID 37974268›Full record

ArticleJournal of nanobiotechnology2023

Topical bismuth oxide-manganese composite nanospheres alleviate atopic dermatitis-like inflammation.

Mengjie Li, Benjin Chen, Lingling Xu, Yu Wang, Zhu Chen, Bingyan Ma, Shichun Qin, Yechun Jiang, Cheng Gu, Haisheng Qian and 1 more

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mengjie Li *Department of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, 230032, Anhui, China.
Benjin Chen *School of Biomedical Engineering, Research and Engineering Center of Biomedical Materials, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, 230032, Anhui, China.
Lingling Xu *School of Biomedical Engineering, Research and Engineering Center of Biomedical Materials, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, 230032, Anhui, China.
Yu WangDepartment of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, 230032, Anhui, China.
Zhu ChenDepartment of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, 230032, Anhui, China.
Bingyan MaDepartment of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, 230032, Anhui, China.
Shichun QinDepartment of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, 230032, Anhui, China.
Yechun JiangSchool of Biomedical Engineering, Research and Engineering Center of Biomedical Materials, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, 230032, Anhui, China.
Cheng GuSchool of Biomedical Engineering, Research and Engineering Center of Biomedical Materials, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, 230032, Anhui, China.
Haisheng QianSchool of Biomedical Engineering, Research and Engineering Center of Biomedical Materials, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, 230032, Anhui, China. shqian@ahmu.edu.cn.
Fengli XiaoDepartment of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, 230032, Anhui, China. xiaofengli@126.com.
Anhui Medical University · CNAnhui University · CN

Funding

Anhui Provincial Institute of Translational Medicine 2021zhyx-B15National Natural Science Foundation of China 81972926
6 · The paper itself

Abstract

Atopic dermatitis (AD) is a common skin disease involving important immune mechanisms. There is an unmet need for a treatment for this condition. Herein, we focused on elucidating the role of Bi

Indexed as

Dermatitis, AtopicNanospheresAnimalsBismuthCytokinesInflammationInterleukin-4ManganeseMiceMice, Inbred C57BLSkinBismuthbismuth oxideCytokinesInterleukin-4ManganeseAtopic dermatitisBi2-xMnxO3 nanospheresIL-4Skin inflammationSTAT6

Identifiers

PMID37974268
PMCPMC10655471
OpenAlexW4388720525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.